prednisolone has been researched along with Local Neoplasm Recurrence in 129 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical analysis indicated that giving 6 days of daily low-dose prednisolone at the time of an upper respiratory tract infection does not reduce the risk of relapse of steroid-sensitive nephrotic syndrome in UK children." | 9.51 | Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT. ( Afentou, N; Bockenhauer, D; Brettell, EA; Christian, MT; Cook, W; Finlay, ER; Frew, E; Gilbert, RD; Hall, AS; Hegde, S; Ives, N; Jones, C; Khan, AR; Koziell, A; Maxwell, H; McKeever, K; Mehta, S; Milford, DV; Saleem, MA; Webb, NJ; Woolley, RL, 2022) |
| "Fourteen patients with recurrent breast cancer were treated with a combination of mitoxantrone (10 mg/m2 iv, day 1), vincristine (1 mg/m2 iv, day 1) and prednisolone (30 mg/day day 1-7)." | 9.08 | [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer]. ( Fukunaga, M; Iba, T; Kidokoro, A; Momose, F; Yagi, Y, 1995) |
| "A prospective randomised trial was performed in patients given HLA-identical sibling bone marrow transplants for haematological malignancy comparing the combination of cyclosporin and methotrexate (CM) (n = 20) with the combination of cyclosporin, methotrexate and prednisolone (CMP) (n = 21) as prophylaxis for graft-versus-host disease (GVHD)." | 9.07 | A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy. ( Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S, 1991) |
| "To determine the effect of prednisolone on severe hypercalcaemia in women with metastatic breast cancer, 30 patients with serum ionized calcium above 1." | 9.07 | Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study. ( Ejlertsen, B; Holmegaard, SN; Krarup-Hansen, A; Kristensen, B; Mouridsen, H; Transbøl, I, 1992) |
| "Objectives The goals of this retrospective study were to evaluate the use of mechlorethamine, vincristine, melphalan and prednisolone (MOMP) chemotherapy for rescue of feline lymphoma, to describe the protocol's toxicity and to determine prognostic indicators for progression-free survival." | 7.88 | Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma. ( Martin, OA; Price, J, 2018) |
| "We analyzed the treatment responses, toxicities, and survival outcomes of patients with relapsed or refractory multiple myeloma who received daily thalidomide, cyclophosphamide, and dexamethasone (CTD) or daily thalidomide, melphalan, and prednisolone (MTP) at 17 medical centers in Korea." | 7.85 | Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study. ( Choi, YS; Eom, HS; Han, JJ; Kang, HJ; Kim, HJ; Kim, K; Kim, MK; Kim, SH; Kwon, J; Lee, JH; Lee, JJ; Lee, JO; Lee, WS; Min, CK; Moon, JH; Yoon, DH; Yoon, SS, 2017) |
| "The administration of oral prednisolone using a standardized protocol of 3 mg/kg given once daily for 1 month, followed by a taper until the infant is 10 months of age, is an effective treatment for infantile hemangioma." | 7.77 | Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. ( Couto, RA; Greene, AK, 2011) |
| "A group of 23 patients with breast cancer were given one course of the following regimen every 3 weeks: mitoxantrone hydrochloride (8 mg/m(2) i." | 7.72 | Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer. ( Aoki, T; Katsumata, K; Koyanagi, Y; Kusama, M; Tomioka, H, 2003) |
| "We treated fifteen patients with recurrent breast cancer by a combination of mitoxantrone (8 mg/m i." | 7.69 | [Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer]. ( Katsumata, K; Kawasaki, M; Koyanagi, Y; Kusama, M; Moriwaki, R; Murano, A; Nagakawa, Y; Ogata, T; Shibata, K; Yamamoto, K, 1997) |
| "The effects of combination chemotherapy including mitoxantrone (MXN) "M-VEMFH" for advanced breast cancer were studied." | 7.67 | [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer]. ( Hoshino, A; Ito, Y; Kamiya, O; Kinoshita, T; Kojima, T; Nagata, K; Ohara, K; Sugiura, I, 1985) |
| "We have recently had a case of a patient with primary malignant lymphoma in whom the diagnosis was difficult and prednisolone was remarkably effective." | 7.66 | [A case of primary malignant lymphoma of the brain which showed a remarkable response to prednisolone]. ( Aki, T; Ichikizaki, K; Iwata, T; Nakamura, T; Nakano, S; Toya, S, 1982) |
| "Multiple myeloma is a malignancy of plasma cells with around 6000 new cases per year in the UK." | 7.11 | MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myeloma. ( Auner, HW; Boyd, K; Brown, S; Garg, M; Hall, A; Kaiser, M; Kendall, J; Roberts, S, 2022) |
| "The clinical analysis indicated that giving 6 days of daily low-dose prednisolone at the time of an upper respiratory tract infection does not reduce the risk of relapse of steroid-sensitive nephrotic syndrome in UK children." | 5.51 | Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT. ( Afentou, N; Bockenhauer, D; Brettell, EA; Christian, MT; Cook, W; Finlay, ER; Frew, E; Gilbert, RD; Hall, AS; Hegde, S; Ives, N; Jones, C; Khan, AR; Koziell, A; Maxwell, H; McKeever, K; Mehta, S; Milford, DV; Saleem, MA; Webb, NJ; Woolley, RL, 2022) |
| "In order to reduce toxic effects while attaining maximal therapeutic effects, epirubicin 10 mg/day, cyclophosphamide 100 mg/day and prednisolone 10 mg/day were administered through in indwelling catheter inserted into the internal mammary artery and/or subclavian artery for 3-4 weeks, employing the implantable port system for the treatment of unresectable breast cancer and recurrent cancer." | 5.08 | [Intra-arterial infusion chemotherapy for breast cancer]. ( Hamada, E; Ikawa, M; Matsumoto, Y; Miura, T; Murata, M; Nakasato, S; Takaki, S; Terakado, H; Watanabe, Y, 1996) |
| "Fourteen patients with recurrent breast cancer were treated with a combination of mitoxantrone (10 mg/m2 iv, day 1), vincristine (1 mg/m2 iv, day 1) and prednisolone (30 mg/day day 1-7)." | 5.08 | [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer]. ( Fukunaga, M; Iba, T; Kidokoro, A; Momose, F; Yagi, Y, 1995) |
| "A prospective randomised trial was performed in patients given HLA-identical sibling bone marrow transplants for haematological malignancy comparing the combination of cyclosporin and methotrexate (CM) (n = 20) with the combination of cyclosporin, methotrexate and prednisolone (CMP) (n = 21) as prophylaxis for graft-versus-host disease (GVHD)." | 5.07 | A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy. ( Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S, 1991) |
| "To determine the effect of prednisolone on severe hypercalcaemia in women with metastatic breast cancer, 30 patients with serum ionized calcium above 1." | 5.07 | Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study. ( Ejlertsen, B; Holmegaard, SN; Krarup-Hansen, A; Kristensen, B; Mouridsen, H; Transbøl, I, 1992) |
| "Objectives The goals of this retrospective study were to evaluate the use of mechlorethamine, vincristine, melphalan and prednisolone (MOMP) chemotherapy for rescue of feline lymphoma, to describe the protocol's toxicity and to determine prognostic indicators for progression-free survival." | 3.88 | Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma. ( Martin, OA; Price, J, 2018) |
| "We analyzed the treatment responses, toxicities, and survival outcomes of patients with relapsed or refractory multiple myeloma who received daily thalidomide, cyclophosphamide, and dexamethasone (CTD) or daily thalidomide, melphalan, and prednisolone (MTP) at 17 medical centers in Korea." | 3.85 | Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study. ( Choi, YS; Eom, HS; Han, JJ; Kang, HJ; Kim, HJ; Kim, K; Kim, MK; Kim, SH; Kwon, J; Lee, JH; Lee, JJ; Lee, JO; Lee, WS; Min, CK; Moon, JH; Yoon, DH; Yoon, SS, 2017) |
| "The administration of oral prednisolone using a standardized protocol of 3 mg/kg given once daily for 1 month, followed by a taper until the infant is 10 months of age, is an effective treatment for infantile hemangioma." | 3.77 | Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. ( Couto, RA; Greene, AK, 2011) |
| "A 42-year-old married woman with a history of Mayer-Rokitansky-Küster-Hauser syndrome, an established neovagina, and complete clinical remission of cutaneous T-cell lymphoma (stage T4) treated with bleomycin, cyclophosphamide, doxorubicin, vincristine and prednisolone had suffered from abdominal pain." | 3.76 | Vaginal obliteration in a woman with a history of cutaneous T-cell lymphoma: the results of combined chemotherapy-induced gonadal toxicity and lymphoma relapse. ( Lee, WL; Pan, CC, 2010) |
| "A consecutive series of 173 women, with data available for 166 of these, presenting with large and locally advanced breast cancer (T2>/=4 cm, T3, T4, or N2) were treated with primary chemotherapy comprising cyclophosphamide, vincristine, doxorubicin, and prednisolone and then surgery (either conservation or mastectomy with axillary surgery) followed by radiotherapy were examined." | 3.72 | Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. ( Heys, SD; Hutcheon, AW; McIntosh, SA; Miller, ID; Ogston, KN; Payne, S; Sarkar, TK, 2003) |
| "A group of 23 patients with breast cancer were given one course of the following regimen every 3 weeks: mitoxantrone hydrochloride (8 mg/m(2) i." | 3.72 | Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer. ( Aoki, T; Katsumata, K; Koyanagi, Y; Kusama, M; Tomioka, H, 2003) |
| "Nine patients with stage III and stage IV thymoma were treated with cisplatin, vincristine, lomustine, cyclophosphamide and prednisolone." | 3.69 | Combination chemotherapy with a five-drug regimen for invasive thymoma. ( Bjerrum, OW; Daugaard, G; Kiss, K, 1996) |
| "We treated fifteen patients with recurrent breast cancer by a combination of mitoxantrone (8 mg/m i." | 3.69 | [Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer]. ( Katsumata, K; Kawasaki, M; Koyanagi, Y; Kusama, M; Moriwaki, R; Murano, A; Nagakawa, Y; Ogata, T; Shibata, K; Yamamoto, K, 1997) |
| "The effects of combination chemotherapy including mitoxantrone (MXN) "M-VEMFH" for advanced breast cancer were studied." | 3.67 | [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer]. ( Hoshino, A; Ito, Y; Kamiya, O; Kinoshita, T; Kojima, T; Nagata, K; Ohara, K; Sugiura, I, 1985) |
| "We have recently had a case of a patient with primary malignant lymphoma in whom the diagnosis was difficult and prednisolone was remarkably effective." | 3.66 | [A case of primary malignant lymphoma of the brain which showed a remarkable response to prednisolone]. ( Aki, T; Ichikizaki, K; Iwata, T; Nakamura, T; Nakano, S; Toya, S, 1982) |
| "Multiple myeloma is a malignancy of plasma cells with around 6000 new cases per year in the UK." | 3.11 | MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myeloma. ( Auner, HW; Boyd, K; Brown, S; Garg, M; Hall, A; Kaiser, M; Kendall, J; Roberts, S, 2022) |
| "Men with high-risk non-metastatic prostate cancer are treated with androgen-deprivation therapy (ADT) for 3 years, often combined with radiotherapy." | 2.82 | Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. ( Alzoueb, M; Amos, CL; Atako, N; Attard, G; Birtle, A; Bowen, J; Brawley, C; Brown, LC; Buckner, M; Chowdhury, S; Clarke, NW; Cook, A; Cross, W; Das, P; de Bono, JS; Dearnaley, DP; Gale, J; Gilbert, D; Gillessen, S; Gilson, C; Gray, E; James, ND; Jones, RJ; Langley, RE; Lydon, A; Malik, Z; Mason, MD; Matheson, D; Millman, R; Murphy, L; O'Sullivan, JM; Parikh, O; Parker, CC; Parmar, MKB; Pedley, I; Pugh, C; Robinson, A; Rush, H; Russell, JM; Srihari, N; Sydes, MR; Syndikus, I; Tanguay, J; Thalmann, G; Thomas, C; Wagstaff, J; Wylie, J; Zarkar, A, 2022) |
| "Of the 86 deaths not attributable to disease progression, 18 (<1%) were caused by a drug-related adverse event, as assessed by the investigator." | 2.79 | Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial. ( Castellano, D; Daugaard, G; De Porre, P; Galli, L; Garrido, JM; Géczi, L; George, DJ; Goon, B; Hotte, SJ; Lee, E; Londhe, A; Mainwaring, PN; McGowan, T; Molina, A; Naini, V; Saad, F; Souza, C; Sternberg, CN; Tay, MH; Todd, MB, 2014) |
| "Treatment with etoposide also evolved as a prognostic factor because the risk of CNS failure was significantly reduced after CHOEP (P=0." | 2.73 | Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). ( Boehme, V; Kaiser, U; Kloess, M; Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S, 2007) |
| "A 47 year old woman with a MALT lymphoma affecting the breast exclusively is reported." | 2.40 | [Primary MALT-type lymphoma of the breast]. ( Campo, E; Cervantes, F; Esteve, J; Montserrat, E; Rafel, M; Serra, A; Velasco, M, 1998) |
| "Prednisolone was started for granulocyte colony-stimulating factor (G-CSF)-induced aortitis, and symptoms and elevated serum inflammatory markers resolved rapidly, allowing early discontinuation of prednisolone." | 1.91 | Granulocyte colony-stimulating factor-induced aortitis with temporal arteritis and monoarthritis. ( Homma, Y; Honda, Y; Iida, K, 2023) |
| "Adults with ulcerative colitis and health-care professionals treating inflammatory bowel disease." | 1.72 | Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study. ( Barr, A; Bedford, H; Blackwell, S; Coates, E; Dames, N; Hind, D; Lee, M; Lobo, A; Probert, C; Sebastian, S; Shackley, P; Totton, N; Wickramasekera, N, 2022) |
| "Systemic steroid treatment improved the stenosis and no recurrence was observed." | 1.56 | Systemic steroid application for treatment of edematous anastomotic stenosis following delta-shaped anastomosis in laparoscopic distal gastrectomy: a case report. ( Arima, J; Hiramatsu, M; Kagota, S; Kobayashi, T; Sakane, J; Suzuki, Y; Taniguchi, K; Tsunematsu, I; Uchiyama, K, 2020) |
| "Histiocytic sarcoma is a rare lymphohematopoietic malignancy with aggressive clinical course and poor therapy response." | 1.48 | A Rare Case of Primary Histiocytic Sarcoma of the Stomach. ( Guenova, ML; Hristoskova, RG; Petkova, NY; Raynov, JI, 2018) |
| "Immune pancytopenia was diagnosed with bone marrow tests and the presence of autoantibodies; it promptly resolved after initiation of prednisolone therapy." | 1.43 | Immune pancytopenia after chemotherapy in a patient with diffuse large B-cell lymphoma. ( Nagai, Y; Nagashima, K; Sugita, Y; Tanaka, H, 2016) |
| "A 64-year-old man presented with diplopia, muscle weakness, a pulmonary nodule and mediastinal widening on a chest radiograph." | 1.42 | Lung cancer associated with seronegative myasthenia gravis. ( Abe, T; Aoki, T; Asano, K; Hayama, N; Horio, Y; Inomoto, C; Murata, N; Nagata, E; Niimi, K; Oguma, T; Sato, M; Takiguchi, H; Takizawa, S; Tanaka, J; Tomomatsu, H; Tomomatsu, K; Urano, T, 2015) |
| "He was diagnosed with minimal change nephrotic syndrome (MCNS) complicated with the recurrence of malignant thymoma." | 1.35 | [Minimal change nephrotic syndrome complicated with recurrence of malignant thymoma: an interesting case with remission due to steroid therapy of both nephrotic syndrome and thymoma]. ( Fujimoto, S; Fukuda, A; Fukudome, K; Hara, S; Iwatsubo, S; Kitamura, K; Komatsu, H; Nishiura, R; Sato, Y; Yamada, K, 2009) |
| "Diagnosis of a giant macroprolactinoma was made and cabergoline was started." | 1.35 | Misdiagnosis due to the hook effect in prolactin assay. ( Arda, N; Comlekci, A; Men, S; Yener, S; Yesil, S, 2008) |
| "Prednisolone treatment (50 mg daily) resulted in dramatic regression of recurrent mediastinal and pleural tumors, as well as improvement of pure red cell aplasia." | 1.34 | [Successful corticosteroid therapy of a recurrent thymoma with pure red cell aplasia]. ( Koshio, J; Maeda, T; Nagasawa, Y; Tsukada, H; Yokoyama, A, 2007) |
| "Acute lymphoblastic leukemia (ALL) can be cured with combination chemotherapy in over 75% of children, but the cause of treatment failure in the remaining patients is unknown." | 1.33 | Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. ( Cheng, C; Cheok, MH; den Boer, ML; Evans, WE; Holleman, A; Janka-Schaub, GE; Lugthart, S; Pieters, R; Pui, CH; Relling, MV; Yang, W, 2005) |
| "The patient was diagnosed as relapse of malignant lymphoma, mainly based on these radiological findings reflecting the mass with high cellularity which grows without destruction of existing vascular structure, and additional chemotherapy was given." | 1.32 | [A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging]. ( Aibe, H; Asayama, Y; Honda, H; Irie, H; Kakihara, D; Matake, K; Nakamura, K; Nakayama, T; Nishie, A; Ohga, S; Tajima, T; Yamamoto, N; Yoshimitsu, K, 2003) |
| "We describe a B cell chronic lymphocytic leukemia/lymphoma (B-CLL) patient with an adrenocortical adenoma." | 1.30 | Functional adrenocortical adenoma in a case with B cell chronic lymphoproliferative disorder. ( Adachi, M; Adachi, Y; Fukushima, H; Hinoda, Y; Imai, K; Takahashi, T, 1997) |
| " Combination of radiotherapy and chemotherapy can improve the survival rate, but the optimal dosage needs to be investigated further." | 1.28 | Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. ( Abe, M; Dodo, Y; Shibamoto, Y; Shima, N; Tsutsui, K; Yamabe, H, 1990) |
| "Treatment with prednisolone brought relief." | 1.28 | Endobronchial pseudolymphoma associated with Sjögren's syndrome. Report of a case. ( Kajiki, A; Kido, M; Kuroiwa, A; Miyazaki, N; Yamazaki, H; Yoashihara, S, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (20.16) | 18.7374 |
| 1990's | 23 (17.83) | 18.2507 |
| 2000's | 25 (19.38) | 29.6817 |
| 2010's | 42 (32.56) | 24.3611 |
| 2020's | 13 (10.08) | 2.80 |
| Authors | Studies |
|---|---|
| Nagasawa, S | 1 |
| Miyazaki, M | 1 |
| Morita, Y | 1 |
| Tanaka, K | 1 |
| Yada, M | 1 |
| Masumoto, A | 1 |
| Motomura, K | 1 |
| Attard, G | 2 |
| Murphy, L | 1 |
| Clarke, NW | 2 |
| Cross, W | 1 |
| Jones, RJ | 2 |
| Parker, CC | 2 |
| Gillessen, S | 2 |
| Cook, A | 1 |
| Brawley, C | 2 |
| Amos, CL | 2 |
| Atako, N | 1 |
| Pugh, C | 1 |
| Buckner, M | 1 |
| Chowdhury, S | 2 |
| Malik, Z | 1 |
| Russell, JM | 2 |
| Gilson, C | 2 |
| Rush, H | 1 |
| Bowen, J | 2 |
| Lydon, A | 1 |
| Pedley, I | 1 |
| O'Sullivan, JM | 1 |
| Birtle, A | 1 |
| Gale, J | 2 |
| Srihari, N | 1 |
| Thomas, C | 2 |
| Tanguay, J | 1 |
| Wagstaff, J | 2 |
| Das, P | 1 |
| Gray, E | 2 |
| Alzoueb, M | 1 |
| Parikh, O | 2 |
| Robinson, A | 2 |
| Syndikus, I | 1 |
| Wylie, J | 2 |
| Zarkar, A | 2 |
| Thalmann, G | 1 |
| de Bono, JS | 2 |
| Dearnaley, DP | 2 |
| Mason, MD | 2 |
| Gilbert, D | 1 |
| Langley, RE | 1 |
| Millman, R | 2 |
| Matheson, D | 2 |
| Sydes, MR | 2 |
| Brown, LC | 1 |
| Parmar, MKB | 2 |
| James, ND | 2 |
| Christian, MT | 1 |
| Webb, NJ | 1 |
| Woolley, RL | 1 |
| Afentou, N | 1 |
| Mehta, S | 1 |
| Frew, E | 1 |
| Brettell, EA | 1 |
| Khan, AR | 1 |
| Milford, DV | 1 |
| Bockenhauer, D | 1 |
| Saleem, MA | 1 |
| Hall, AS | 1 |
| Koziell, A | 1 |
| Maxwell, H | 1 |
| Hegde, S | 1 |
| Finlay, ER | 1 |
| Gilbert, RD | 1 |
| Jones, C | 1 |
| McKeever, K | 1 |
| Cook, W | 1 |
| Ives, N | 1 |
| Ueno, M | 1 |
| Takabatake, H | 1 |
| Hata, A | 1 |
| Kayahara, T | 1 |
| Morimoto, Y | 1 |
| Notohara, K | 1 |
| Mizuno, M | 1 |
| Sakae, H | 1 |
| Mawatari, S | 1 |
| Oda, K | 1 |
| Tabu, K | 1 |
| Kumagai, K | 2 |
| Mizuno, K | 1 |
| Nozuma, S | 1 |
| Kitazono, I | 1 |
| Kanmura, S | 1 |
| Ido, A | 1 |
| Horiuchi, Y | 1 |
| Hashimoto, K | 2 |
| Horikoshi, H | 1 |
| Sano, A | 1 |
| Kawamura, Y | 1 |
| Fujita, N | 1 |
| Kimata, M | 1 |
| Ono, Y | 1 |
| Obuchi, Y | 1 |
| Makino, A | 1 |
| Kaneko, M | 1 |
| Kimura, F | 1 |
| Itoh, K | 1 |
| Tanaka, Y | 1 |
| Choi, JH | 1 |
| Lim, I | 1 |
| Byun, BH | 1 |
| Kim, BI | 1 |
| Choi, CW | 1 |
| Kang, HJ | 3 |
| Shin, DY | 1 |
| Lim, SM | 1 |
| Kendall, J | 1 |
| Hall, A | 1 |
| Roberts, S | 1 |
| Brown, S | 1 |
| Boyd, K | 1 |
| Auner, HW | 1 |
| Garg, M | 1 |
| Kaiser, M | 1 |
| Coates, E | 1 |
| Wickramasekera, N | 1 |
| Barr, A | 1 |
| Shackley, P | 1 |
| Lee, M | 1 |
| Hind, D | 1 |
| Probert, C | 1 |
| Sebastian, S | 1 |
| Totton, N | 1 |
| Blackwell, S | 1 |
| Bedford, H | 1 |
| Dames, N | 1 |
| Lobo, A | 1 |
| Ohwada, S | 3 |
| Ishigami, K | 3 |
| Yokoyama, Y | 3 |
| Kazama, T | 3 |
| Masaki, Y | 4 |
| Takahashi, M | 3 |
| Yoshii, S | 3 |
| Yamano, HO | 3 |
| Chiba, H | 3 |
| Nakase, H | 3 |
| Iida, K | 1 |
| Honda, Y | 1 |
| Homma, Y | 1 |
| Onozato, Y | 1 |
| Sasaki, Y | 1 |
| Abe, Y | 1 |
| Yaoita, T | 1 |
| Yagi, M | 1 |
| Mizumoto, N | 1 |
| Shoji, M | 1 |
| Kon, T | 1 |
| Sakai, T | 2 |
| Ueno, Y | 1 |
| Arima, J | 1 |
| Taniguchi, K | 1 |
| Kobayashi, T | 1 |
| Tsunematsu, I | 1 |
| Kagota, S | 1 |
| Sakane, J | 1 |
| Suzuki, Y | 1 |
| Uchiyama, K | 1 |
| Hiramatsu, M | 1 |
| Ono, K | 1 |
| Ise, M | 1 |
| Ikebe, D | 1 |
| Sato, A | 1 |
| Wang, X | 2 |
| Sugawara, T | 1 |
| Tsujimura, H | 1 |
| Itami, M | 1 |
| Hwang, YY | 1 |
| Khong, PL | 1 |
| Kwong, YL | 1 |
| Kiyohara, Y | 1 |
| Yoshikawa, S | 1 |
| Otsuka, M | 1 |
| Kondou, R | 1 |
| Iizuka, A | 1 |
| Nonomura, C | 1 |
| Ohshima, K | 1 |
| Urakami, K | 1 |
| Kusuhara, M | 1 |
| Nagashima, T | 1 |
| Sugino, T | 1 |
| Yamaguchi, K | 2 |
| Akiyama, Y | 1 |
| Spears, MR | 1 |
| Ritchie, AWS | 1 |
| Cross, WR | 1 |
| Berthold, DR | 1 |
| Adab, F | 1 |
| Aung, S | 1 |
| Birtle, AJ | 1 |
| Brock, S | 1 |
| Chakraborti, P | 1 |
| Ferguson, C | 1 |
| Hingorani, M | 1 |
| Hoskin, PJ | 1 |
| Lester, JF | 1 |
| Malik, ZI | 1 |
| McKinna, F | 1 |
| McPhail, N | 1 |
| Money-Kyrle, J | 1 |
| O'Sullivan, J | 1 |
| Protheroe, A | 1 |
| Srihari, NN | 1 |
| Bavcar, S | 1 |
| de Vos, J | 1 |
| Kessler, M | 1 |
| de Fornel, P | 1 |
| Buracco, P | 1 |
| Murphy, S | 1 |
| Hirschberger, J | 1 |
| Argyle, DJ | 1 |
| Martin, OA | 1 |
| Price, J | 1 |
| MacManus, M | 1 |
| Fisher, R | 1 |
| Roos, D | 1 |
| O'Brien, P | 1 |
| Macann, A | 1 |
| Davis, S | 1 |
| Tsang, R | 1 |
| Christie, D | 1 |
| McClure, B | 1 |
| Joseph, D | 1 |
| Jayamohan, J | 1 |
| Seymour, JF | 1 |
| Petkova, NY | 1 |
| Hristoskova, RG | 1 |
| Guenova, ML | 1 |
| Raynov, JI | 1 |
| Yamada, T | 1 |
| Masuda, T | 1 |
| Sakamoto, S | 1 |
| Horimasu, Y | 1 |
| Miyamoto, S | 1 |
| Nakashima, T | 1 |
| Iwamoto, H | 1 |
| Hirata, S | 1 |
| Fujitaka, K | 1 |
| Hamada, H | 1 |
| Sugiyama, E | 1 |
| Hattori, N | 1 |
| Ohe, M | 1 |
| Hashino, S | 1 |
| Naqi, N | 1 |
| Ahmad, S | 1 |
| Shah, I | 1 |
| Khattak, J | 1 |
| Lowry, L | 1 |
| Smith, P | 1 |
| Cunningham, D | 2 |
| Linch, DC | 1 |
| Lee, JW | 1 |
| Shin, HY | 1 |
| Kim, H | 1 |
| Park, JD | 1 |
| Park, KD | 1 |
| Kim, HS | 1 |
| Park, SH | 1 |
| Wang, KC | 1 |
| Ahn, HS | 1 |
| Koh, K | 2 |
| Tomizawa, D | 1 |
| Moriya Saito, A | 1 |
| Watanabe, T | 1 |
| Miyamura, T | 1 |
| Hirayama, M | 1 |
| Takahashi, Y | 1 |
| Ogawa, A | 1 |
| Kato, K | 1 |
| Sugita, K | 2 |
| Sato, T | 2 |
| Deguchi, T | 1 |
| Hayashi, Y | 1 |
| Takita, J | 1 |
| Takeshita, Y | 1 |
| Tsurusawa, M | 1 |
| Horibe, K | 1 |
| Mizutani, S | 1 |
| Ishii, E | 1 |
| Alig, SK | 1 |
| Dreyling, M | 1 |
| Seppi, B | 1 |
| Aulinger, B | 1 |
| Witkowski, L | 1 |
| Rieger, CT | 1 |
| Coiffier, B | 2 |
| Federico, M | 1 |
| Caballero, D | 1 |
| Dearden, C | 1 |
| Morschhauser, F | 1 |
| Jäger, U | 1 |
| Trümper, L | 2 |
| Zucca, E | 1 |
| Gomes da Silva, M | 1 |
| Pettengell, R | 1 |
| Weidmann, E | 1 |
| d'Amore, F | 1 |
| Tilly, H | 1 |
| Zinzani, PL | 1 |
| Dahut, WL | 1 |
| Madan, RA | 1 |
| Sternberg, CN | 1 |
| Castellano, D | 1 |
| Daugaard, G | 2 |
| Géczi, L | 1 |
| Hotte, SJ | 1 |
| Mainwaring, PN | 1 |
| Saad, F | 1 |
| Souza, C | 1 |
| Tay, MH | 1 |
| Garrido, JM | 1 |
| Galli, L | 1 |
| Londhe, A | 1 |
| De Porre, P | 1 |
| Goon, B | 1 |
| Lee, E | 1 |
| McGowan, T | 1 |
| Naini, V | 1 |
| Todd, MB | 1 |
| Molina, A | 1 |
| George, DJ | 1 |
| Navinan, MR | 1 |
| Liyanage, I | 1 |
| Herath, S | 1 |
| Yudhishdran, J | 1 |
| Shivanthan, C | 1 |
| Beneragama, D | 1 |
| Kulatunga, A | 1 |
| Fayad, L | 1 |
| Ansell, SM | 1 |
| Advani, R | 1 |
| Stuart, R | 1 |
| Bartlett, NL | 1 |
| Forero-Torres, A | 1 |
| Kuliczkowski, K | 1 |
| Belada, D | 1 |
| Ng, E | 1 |
| Drachman, JG | 1 |
| Vlenterie, M | 1 |
| van Erp, NP | 1 |
| van der Graaf, WT | 1 |
| Tseng, YD | 1 |
| Chen, YH | 1 |
| Catalano, PJ | 1 |
| Ng, A | 1 |
| Paugh, SW | 1 |
| Bonten, EJ | 1 |
| Savic, D | 1 |
| Ramsey, LB | 1 |
| Thierfelder, WE | 1 |
| Gurung, P | 1 |
| Malireddi, RK | 1 |
| Actis, M | 1 |
| Mayasundari, A | 1 |
| Min, J | 1 |
| Coss, DR | 1 |
| Laudermilk, LT | 1 |
| Panetta, JC | 1 |
| McCorkle, JR | 1 |
| Fan, Y | 1 |
| Crews, KR | 1 |
| Stocco, G | 1 |
| Wilkinson, MR | 1 |
| Ferreira, AM | 1 |
| Cheng, C | 2 |
| Yang, W | 2 |
| Karol, SE | 1 |
| Fernandez, CA | 1 |
| Diouf, B | 1 |
| Smith, C | 1 |
| Hicks, JK | 1 |
| Zanut, A | 1 |
| Giordanengo, A | 1 |
| Crona, D | 1 |
| Bianchi, JJ | 1 |
| Holmfeldt, L | 1 |
| Mullighan, CG | 1 |
| den Boer, ML | 2 |
| Pieters, R | 2 |
| Jeha, S | 1 |
| Dunwell, TL | 1 |
| Latif, F | 1 |
| Bhojwani, D | 1 |
| Carroll, WL | 1 |
| Pui, CH | 3 |
| Myers, RM | 1 |
| Guy, RK | 1 |
| Kanneganti, TD | 1 |
| Relling, MV | 2 |
| Evans, WE | 2 |
| Niimi, K | 1 |
| Nagata, E | 1 |
| Murata, N | 1 |
| Sato, M | 1 |
| Tanaka, J | 1 |
| Horio, Y | 1 |
| Takiguchi, H | 1 |
| Tomomatsu, H | 1 |
| Tomomatsu, K | 1 |
| Hayama, N | 1 |
| Oguma, T | 1 |
| Aoki, T | 2 |
| Urano, T | 1 |
| Abe, T | 1 |
| Inomoto, C | 1 |
| Takizawa, S | 1 |
| Asano, K | 1 |
| Toyoshima, D | 1 |
| Morisada, N | 1 |
| Takami, Y | 1 |
| Kidokoro, H | 1 |
| Nishiyama, M | 1 |
| Nakagawa, T | 1 |
| Ninchoji, T | 1 |
| Nozu, K | 1 |
| Takeshima, Y | 1 |
| Takada, S | 1 |
| Nishio, H | 1 |
| Iijima, K | 1 |
| Beaven, AW | 1 |
| Diehl, LF | 1 |
| Friedberg, JW | 1 |
| Kmieciak, L | 1 |
| Hague, DW | 1 |
| Neumann, ZL | 1 |
| Joslyn, S | 1 |
| Hedermann, G | 1 |
| Marquart, HV | 1 |
| Vissing, J | 1 |
| Nagashima, K | 1 |
| Tanaka, H | 1 |
| Nagai, Y | 1 |
| Sugita, Y | 1 |
| Kwon, J | 1 |
| Min, CK | 1 |
| Kim, K | 1 |
| Han, JJ | 1 |
| Moon, JH | 1 |
| Eom, HS | 1 |
| Kim, MK | 1 |
| Kim, HJ | 1 |
| Yoon, DH | 1 |
| Lee, JO | 1 |
| Lee, WS | 1 |
| Lee, JH | 1 |
| Lee, JJ | 1 |
| Choi, YS | 1 |
| Kim, SH | 1 |
| Yoon, SS | 1 |
| Yener, S | 1 |
| Comlekci, A | 1 |
| Arda, N | 1 |
| Men, S | 1 |
| Yesil, S | 1 |
| Fukuda, A | 1 |
| Sato, Y | 1 |
| Iwatsubo, S | 1 |
| Komatsu, H | 1 |
| Nishiura, R | 1 |
| Fukudome, K | 1 |
| Yamada, K | 1 |
| Hara, S | 1 |
| Fujimoto, S | 1 |
| Kitamura, K | 1 |
| Ito, J | 1 |
| Sekiya, M | 1 |
| Miura, K | 1 |
| Yoshimi, K | 1 |
| Suzuki, T | 1 |
| Seyama, K | 1 |
| Izumi, H | 1 |
| Uekusa, T | 1 |
| Takahashi, K | 1 |
| Pan, CC | 1 |
| Lee, WL | 1 |
| Miki, M | 1 |
| Nakamura, T | 3 |
| Iwao, H | 1 |
| Nakajima, A | 1 |
| Sawaki, T | 1 |
| Kawanami, T | 1 |
| Kaito, M | 1 |
| Kurose, N | 1 |
| Fujita, Y | 1 |
| Tanaka, M | 1 |
| Fukushima, T | 2 |
| Hirose, Y | 1 |
| Umehara, H | 1 |
| Hasegawa, D | 1 |
| Manabe, A | 2 |
| Ohara, A | 2 |
| Kikuchi, A | 1 |
| Kiyokawa, N | 1 |
| Ishida, Y | 1 |
| Saito, T | 2 |
| Hanada, R | 2 |
| Tsuchida, M | 2 |
| Ono, M | 1 |
| Ohnishi, S | 1 |
| Onishi, R | 1 |
| Takahashi, S | 1 |
| Kobayashi, Y | 1 |
| Suzuki, M | 1 |
| Kubo, K | 1 |
| Dazai, M | 1 |
| Yamamoto, J | 1 |
| Oda, H | 1 |
| Tada, K | 1 |
| Takahashi, T | 2 |
| Miyagishima, T | 1 |
| Shimada, K | 1 |
| Greene, AK | 1 |
| Couto, RA | 1 |
| Mitteldorf, C | 1 |
| Bertsch, HP | 1 |
| Baumgart, M | 1 |
| Haase, D | 1 |
| Wulf, G | 1 |
| Schön, MP | 1 |
| Rosenwald, A | 1 |
| Neumann, C | 1 |
| Kaune, KM | 1 |
| Chen, XG | 1 |
| Huang, H | 1 |
| Tian, Y | 1 |
| Guo, CC | 1 |
| Liang, CY | 1 |
| Gong, YL | 1 |
| Zou, BY | 1 |
| Cai, RQ | 1 |
| Lin, TY | 1 |
| Nishioka, M | 1 |
| Igawa, K | 1 |
| Yahata, Y | 1 |
| Tani, M | 1 |
| Katayama, I | 2 |
| Nakazawa, S | 2 |
| Shimizu, K | 1 |
| Nakano, T | 1 |
| Kakegawa, S | 1 |
| Atsumi, J | 1 |
| Kamiyoshihara, M | 1 |
| Hirato, J | 1 |
| Takeyoshi, I | 1 |
| Perry, CJ | 1 |
| Sundar, S | 1 |
| Rummel, MJ | 1 |
| Mitrou, PS | 1 |
| Hoelzer, D | 1 |
| Katsumata, K | 2 |
| Tomioka, H | 1 |
| Kusama, M | 2 |
| Koyanagi, Y | 2 |
| McIntosh, SA | 1 |
| Ogston, KN | 1 |
| Payne, S | 1 |
| Miller, ID | 1 |
| Sarkar, TK | 1 |
| Hutcheon, AW | 1 |
| Heys, SD | 1 |
| CLUXTON, HE | 1 |
| Yamamoto, N | 1 |
| Nishie, A | 1 |
| Yoshimitsu, K | 1 |
| Irie, H | 1 |
| Aibe, H | 1 |
| Tajima, T | 1 |
| Asayama, Y | 1 |
| Matake, K | 1 |
| Nakayama, T | 1 |
| Kakihara, D | 1 |
| Ohga, S | 1 |
| Nakamura, K | 1 |
| Honda, H | 1 |
| Hennequin, C | 1 |
| Espié, M | 1 |
| Misset, JL | 1 |
| Maylin, C | 1 |
| Ohta, M | 1 |
| Takeshita, I | 1 |
| Matsumoto, K | 1 |
| Matsuoka, S | 1 |
| Ikeda, K | 1 |
| Lugthart, S | 1 |
| Cheok, MH | 1 |
| Holleman, A | 1 |
| Janka-Schaub, GE | 1 |
| Miller, MA | 1 |
| Sandler, AD | 1 |
| Yong, W | 1 |
| Zheng, W | 1 |
| Zhu, J | 1 |
| Zhang, Y | 1 |
| Wei, Y | 1 |
| Lin, N | 1 |
| Xie, Y | 1 |
| Xu, B | 1 |
| Li, J | 1 |
| Ducray, F | 1 |
| Colin, P | 1 |
| Cartalat-Carel, S | 1 |
| Pelissou-Guyotat, I | 1 |
| Mahla, K | 1 |
| Audra, P | 1 |
| Gaucherand, P | 1 |
| Honnorat, J | 1 |
| Trouillas, P | 1 |
| Magro, CM | 1 |
| Seilstad, KH | 1 |
| Porcu, P | 1 |
| Morrison, CD | 1 |
| Pascual, J | 1 |
| Fernández, AM | 1 |
| Marcén, R | 1 |
| Ortuño, J | 1 |
| Boehme, V | 1 |
| Zeynalova, S | 1 |
| Kloess, M | 1 |
| Loeffler, M | 2 |
| Kaiser, U | 1 |
| Pfreundschuh, M | 1 |
| Schmitz, N | 1 |
| Mani, R | 1 |
| Belcadhi, M | 1 |
| Krifa, N | 1 |
| Sriha, B | 1 |
| Elomri, H | 1 |
| Ben Ali, M | 1 |
| Abdelkéfi, M | 1 |
| Bouzouita, K | 1 |
| Ushio, M | 1 |
| Takeuchi, N | 1 |
| Kikuchi, S | 1 |
| Kaga, K | 1 |
| Capra, M | 1 |
| Hewitt, M | 1 |
| Radford, M | 1 |
| Hayward, J | 1 |
| Weston, CL | 1 |
| Machin, D | 1 |
| Song, EK | 1 |
| Kim, SY | 1 |
| Kim, TM | 1 |
| Lee, KW | 1 |
| Yun, T | 1 |
| Na, II | 1 |
| Shin, H | 1 |
| Lee, SH | 1 |
| Kim, DW | 1 |
| Khwarg, SI | 1 |
| Heo, DS | 1 |
| Koshio, J | 1 |
| Tsukada, H | 1 |
| Nagasawa, Y | 1 |
| Maeda, T | 1 |
| Yokoyama, A | 1 |
| Rabadi, SJ | 1 |
| Haid, M | 1 |
| Scanlon, EF | 1 |
| Khandekar, JD | 1 |
| Caprini, JA | 1 |
| Oviedo, MA | 1 |
| Cunningham, MP | 1 |
| Grizenko, KK | 1 |
| Cohen, E | 1 |
| Wilms, K | 1 |
| Link, H | 1 |
| Meyer, P | 1 |
| Ostendorf, P | 1 |
| Schüch, K | 1 |
| Waller, HD | 1 |
| Wernet, P | 1 |
| Niethammer, D | 1 |
| Dopfer, H | 1 |
| Schneider, W | 1 |
| Schunter, F | 1 |
| Breitling, G | 1 |
| Frommhold, W | 1 |
| Seeger, G | 1 |
| Voss, AC | 1 |
| Vialushkin, BIa | 1 |
| Koshel', IV | 1 |
| Tsyplenkov, VG | 1 |
| Monfardini, S | 1 |
| Banfi, A | 1 |
| Bonadonna, G | 1 |
| Rilke, F | 1 |
| Milani, F | 1 |
| Valagussa, P | 1 |
| Lattuada, A | 1 |
| Gallmeier, WM | 1 |
| Bruntsch, U | 1 |
| Aki, T | 1 |
| Ichikizaki, K | 1 |
| Iwata, T | 1 |
| Toya, S | 1 |
| Nakano, S | 1 |
| Timothy, AR | 1 |
| Sutcliffe, SB | 1 |
| Lister, TA | 1 |
| Wrigley, PF | 1 |
| Jones, AE | 1 |
| Iba, T | 1 |
| Yagi, Y | 1 |
| Kidokoro, A | 1 |
| Fukunaga, M | 1 |
| Momose, F | 1 |
| van Camp, C | 1 |
| Clement, PA | 1 |
| Toogood, IR | 1 |
| Tiedemann, K | 1 |
| Stevens, M | 1 |
| Smith, PJ | 1 |
| Bjerrum, OW | 1 |
| Kiss, K | 1 |
| Matsumoto, Y | 1 |
| Terakado, H | 1 |
| Ikawa, M | 1 |
| Hamada, E | 1 |
| Watanabe, Y | 1 |
| Nakasato, S | 1 |
| Takaki, S | 1 |
| Murata, M | 1 |
| Miura, T | 1 |
| Levin, M | 1 |
| Aziz, M | 1 |
| Opitz, L | 1 |
| Adachi, Y | 1 |
| Adachi, M | 1 |
| Hinoda, Y | 1 |
| Fukushima, H | 1 |
| Imai, K | 1 |
| Ono, H | 1 |
| Yokozeki, H | 1 |
| Nishioka, K | 1 |
| Yamamoto, K | 1 |
| Shibata, K | 1 |
| Murano, A | 1 |
| Kawasaki, M | 1 |
| Moriwaki, R | 1 |
| Nagakawa, Y | 1 |
| Ogata, T | 1 |
| Emura, I | 1 |
| Chou, T | 1 |
| Ishiguro, T | 1 |
| Kakihara, T | 1 |
| Naito, M | 1 |
| Yoshizawa, H | 1 |
| Arakawa, M | 1 |
| Veness, MJ | 1 |
| Rafel, M | 1 |
| Esteve, J | 1 |
| Cervantes, F | 1 |
| Velasco, M | 1 |
| Serra, A | 1 |
| Campo, E | 1 |
| Montserrat, E | 1 |
| Pichler, R | 1 |
| Hatzl-Griesenhofer, M | 1 |
| Huber, H | 1 |
| Wimmer, G | 1 |
| Wahl, G | 1 |
| Maschek, W | 1 |
| Wu, HG | 1 |
| Kim, IH | 1 |
| Ha, SW | 1 |
| Park, CI | 1 |
| Bang, YJ | 1 |
| Huh, DS | 1 |
| Guenther, PP | 1 |
| Huebner, A | 1 |
| Sobottka, SB | 1 |
| Neumeister, V | 1 |
| Weissbach, G | 1 |
| Todt, H | 1 |
| Parwaresch, R | 1 |
| Ikuta, K | 1 |
| Toyoda, Y | 1 |
| Okimoto, Y | 1 |
| Ishimoto, K | 1 |
| Okawa, H | 1 |
| Kaneko, T | 1 |
| Koike, K | 1 |
| Bessho, F | 1 |
| Hoshi, Y | 1 |
| Maeda, M | 1 |
| Kinoshita, A | 1 |
| Tsunematsu, Y | 1 |
| Rübe, C | 1 |
| Nguyen, TP | 1 |
| Klöss, M | 1 |
| Pfreunschuh, M | 1 |
| Ingram, RM | 1 |
| Williams, ME | 1 |
| Fintel, WA | 1 |
| Ross, M | 1 |
| Murphy, GP | 1 |
| Leventhal, BG | 1 |
| Levine, AS | 1 |
| Graw, RG | 1 |
| Simon, R | 1 |
| Freireich, EJ | 1 |
| Henderson, ES | 1 |
| Gilbert, HA | 1 |
| Yettra, M | 1 |
| Gordon, J | 1 |
| Kagan, AR | 1 |
| Kristensen, B | 1 |
| Ejlertsen, B | 1 |
| Holmegaard, SN | 1 |
| Krarup-Hansen, A | 1 |
| Transbøl, I | 1 |
| Mouridsen, H | 1 |
| Oza, AM | 1 |
| Ganesan, TS | 1 |
| Dorreen, M | 1 |
| Johnson, PW | 1 |
| Waxman, J | 1 |
| Gregory, W | 1 |
| Lim, J | 1 |
| Wright, J | 1 |
| Dadiotis, L | 1 |
| Barbounis, V | 1 |
| Singletary, SE | 1 |
| McNeese, MD | 1 |
| Hortobagyi, GN | 1 |
| Nakagawa, H | 1 |
| Tanaka, S | 1 |
| Takashima, T | 1 |
| Shizumi, Y | 1 |
| Nishigaki, H | 1 |
| Horiike, S | 1 |
| Taniwaki, M | 1 |
| Misawa, S | 1 |
| Kashima, K | 1 |
| Hironaka, T | 1 |
| Perren, TJ | 1 |
| Selby, PJ | 1 |
| Milan, S | 1 |
| Meldrum, M | 1 |
| McElwain, TJ | 1 |
| Atkinson, K | 1 |
| Biggs, J | 1 |
| Concannon, A | 1 |
| Dodds, A | 1 |
| Young, S | 1 |
| Wilson, F | 1 |
| Ashby, M | 1 |
| Downs, K | 1 |
| Anderson, H | 1 |
| Crowther, D | 1 |
| Deakin, DP | 1 |
| Ryder, WD | 1 |
| Radford, JA | 1 |
| Dahl, GV | 1 |
| Kalwinsky, DK | 1 |
| Mirro, J | 1 |
| Look, AT | 1 |
| Murphy, SB | 1 |
| Mason, C | 1 |
| Ruggiero, M | 1 |
| Schell, M | 1 |
| Johnson, FL | 1 |
| Shibamoto, Y | 1 |
| Tsutsui, K | 1 |
| Dodo, Y | 1 |
| Yamabe, H | 1 |
| Shima, N | 1 |
| Abe, M | 1 |
| Yamazaki, H | 2 |
| Kuraishi, Y | 1 |
| Takasaki, N | 1 |
| Ozeki, H | 1 |
| Mashizu, N | 1 |
| Nagamine, D | 1 |
| Usui, N | 1 |
| Aiba, K | 1 |
| Yokoyama, K | 1 |
| Hepplestone, A | 1 |
| Gilchrist, NL | 1 |
| Dagg, JH | 1 |
| Evans, IL | 1 |
| Soukop, M | 1 |
| Yoshida, T | 1 |
| Nakamura, S | 1 |
| Ohtake, S | 1 |
| Kobayashi, K | 1 |
| Kanno, M | 1 |
| Matsuda, T | 1 |
| Matano, S | 1 |
| Kondo, K | 1 |
| Okafuji, K | 1 |
| Kanai, M | 1 |
| Miyazaki, N | 1 |
| Kido, M | 1 |
| Kajiki, A | 1 |
| Yoashihara, S | 1 |
| Kuroiwa, A | 1 |
| Domingo Albós, A | 1 |
| Callís, M | 1 |
| Juliá, A | 1 |
| Vilá, J | 1 |
| Zuazu, J | 1 |
| Puig, J | 1 |
| Petit, J | 1 |
| Fernández-Sevilla, A | 1 |
| O'Grady, JG | 1 |
| Johnson, PJ | 1 |
| Zaman, S | 1 |
| Calne, RY | 1 |
| Williams, R | 1 |
| van Eys, J | 1 |
| Berry, D | 1 |
| Crist, W | 1 |
| Doering, E | 1 |
| Fernbach, D | 1 |
| Pullen, J | 1 |
| Shuster, J | 1 |
| Wharam, M | 1 |
| Tsukasaki, K | 1 |
| Ikeda, S | 1 |
| Momita, S | 1 |
| Nagai, K | 1 |
| Murata, K | 1 |
| Tokunaga, S | 1 |
| Kohno, T | 1 |
| Itoyama, T | 1 |
| Toriya, K | 1 |
| Kuriyama, K | 1 |
| Baĭsogolov, GD | 1 |
| Pavlov, VV | 1 |
| Shakhtarina, SV | 1 |
| Mustiatsé, LZ | 1 |
| Korchmaru, IF | 1 |
| Ito, Y | 1 |
| Hoshino, A | 1 |
| Ohara, K | 1 |
| Kamiya, O | 1 |
| Nagata, K | 1 |
| Kojima, T | 1 |
| Kinoshita, T | 1 |
| Sugiura, I | 1 |
| Akagawa, S | 1 |
| Murota, N | 1 |
| Tanoue, M | 1 |
| Ohdama, S | 1 |
| Chida, M | 1 |
| Miyazato, I | 1 |
| Matsubara, O | 1 |
| Tanaka, T | 1 |
| Mitsunaga, K | 1 |
| Van der Riet, Fde S | 1 |
| Kahn, LB | 1 |
| Berglund, G | 1 |
| Vishniakova, EG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial[NCT00268476] | Phase 2/Phase 3 | 11,992 participants (Actual) | Interventional | 2005-07-08 | Active, not recruiting | ||
| Safety and Efficacy Evaluation of Low-dose Nivolumab in Combination With AVD as Frontline Therapy for Classic Hodgkin's Lymphoma[NCT05772624] | Phase 2 | 16 participants (Anticipated) | Interventional | 2023-02-13 | Recruiting | ||
| A Randomized Phase II Trial Comparing Biomarker Directed Therapy Versus Clinician's Choice of Enzalutamide or Docetaxel in Patients With Advanced Prostate Cancer Post Abiraterone[NCT04015622] | Phase 2 | 100 participants (Anticipated) | Interventional | 2020-10-07 | Recruiting | ||
| A Single-center, Phase II Neoadjuvant Study of Abiraterone Acetate in the Treatment of Intraductal Carcinoma of the Prostate[NCT04736108] | Phase 2 | 50 participants (Anticipated) | Interventional | 2021-05-31 | Not yet recruiting | ||
| An Open-label, Phase I/IIa Dose Escalation and Expansion Study to Determine the Safety and Clinical Activity of an Immune Priming Cell Therapy (INKmune) in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)[NCT06056791] | Phase 1/Phase 2 | 30 participants (Anticipated) | Interventional | 2023-11-30 | Not yet recruiting | ||
| A Randomised Multicentre Trial of Involved Field Radiotherapy Versus Involved Field Radiotherapy Plus Chemotherapy in Combination With Rituximab (Mabthera®) for Stage I - II Low Grade Follicular Lymphoma[NCT00115700] | Phase 3 | 150 participants (Actual) | Interventional | 2000-02-29 | Completed | ||
| An Open Label Study of Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy[NCT01217697] | 0 participants | Expanded Access | Approved for marketing | ||||
| A Randomized Phase IIb Placebo-controlled Study of R-ICE Chemotherapy With and Without SGN-40 (Anti-CD40 Humanized Monoclonal Antibody) for Second-line Treatment of Patients With Diffuse Large B-Cell Lymphoma (DLBCL)[NCT00529503] | Phase 2 | 151 participants (Actual) | Interventional | 2007-09-30 | Terminated | ||
| Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia[NCT00137111] | Phase 3 | 501 participants (Actual) | Interventional | 2000-07-08 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"White blood cell (leukocytes) counts in peripheral blood by Complete Blood Count~Measurement: Percentage change of leukemia cells from baseline" (NCT00137111)
Timeframe: Immediately before the methotrexate infusion and three days after subsequent infusion
| Intervention | Percent change (Mean) |
|---|---|
| 4 hr | -44 |
| 24 hr | -50 |
CCR was measured from end of week 56 therapy to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Measurement was determined by Kaplan-Meyer estimate. (NCT00137111)
Timeframe: Median follow up time (range) 4.5 (1 to 7.8) years
| Intervention | Percentage of participants (Number) |
|---|---|
| Patients With High Risk of CNS Relapse | 92.2 |
Children were randomly assigned to receive initial single-agent treatment with HDMTX (1g/m^2) as either a 24-hour infusion or a 4-hour infusion and the outcome measure was the accumulation of MTXPG in leukemia cells. (NCT00137111)
Timeframe: 42 hours after start of high dose methotrexate infusion (HDMTX)
| Intervention | pmol/1,000,000,000 cells (Mean) |
|---|---|
| 4 hr | 1688 |
| 24 hr | 2521 |
EFS was measured from the start of on-study to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Failure to enter remission was considered an event at time zero. Measurement was determined by Kaplan-Meyer estimate. (NCT00137111)
Timeframe: Median follow-up time (range) 5.6 (1.3 to 8.9) years
| Intervention | Percentage of Participants (Number) |
|---|---|
| Total Therapy | 87.3 |
Prednisolone sensitivity was measured in primary leukemia cells from bone marrow collected at diagnosis. Expression of CASP1 was determined by HG-U133A microarray. Values given are gene expression values, and the unit is arbitrary units (AU) defined as scaled fluorescence measured on microarray. (NCT00137111)
Timeframe: Pre-treatment
| Intervention | arbitrary units (Median) | |
|---|---|---|
| Prednisolone-sensitive cells | Prednisolone-resistant cells | |
| Total Therapy | 341.3 | 447.9 |
Prednisolone sensitivity was measured in primary leukemia cells from bone marrow collected at diagnosis. Expression of NLRP3 was determined by HG-U133A microarray. Values given are gene expression values, and the unit is arbitrary units (AU) defined as scaled fluorescence measured on microarray. (NCT00137111)
Timeframe: Pre-treatment
| Intervention | arbitrary units (Median) | |
|---|---|---|
| Prednisolone-sensitive cells | Prednisolone-resistant cells | |
| Total Therapy | 41.2 | 110.7 |
Detection of MRD at end of induction where positive MRD was defined as one or more leukemic cell per 10,000 mononuclear bone-marrow cells (>=0.01%). (NCT00137111)
Timeframe: End of Induction (Day 46 MRD measurement)
| Intervention | participants (Number) | |
|---|---|---|
| Negative <0.01% | Positive >= 0.01% | |
| Total Therapy | 390 | 102 |
12 reviews available for prednisolone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chemotherapy, Adjuv | 2022 |
Mycophenolate mofetil for immune checkpoint inhibitor-related hepatotoxicity relapsing during dose reduction of corticosteroid: A report of two cases and literature review.
Topics: Adrenal Cortex Hormones; Aged; Chemical and Drug Induced Liver Injury; Drug Tapering; Humans; Immune | 2022 |
Cronkhite-Canada Syndrome Associated with Gastric Outlet Obstruction and Membranous Nephropathy: A Case Report and Review of the Literature.
Topics: Gastric Outlet Obstruction; Glomerulonephritis, Membranous; Humans; Intestinal Polyposis; Male; Midd | 2020 |
Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclopho | 2015 |
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemo | 2014 |
Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma: time for a precision medicine approach.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Genotype; Humans; Imm | 2015 |
[Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; C | 2011 |
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2002 |
[Does primary chemotherapy really increase the rate of breast conserving treatments?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Cy | 2004 |
[Primary MALT-type lymphoma of the breast].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1998 |
Testicular lymphoma: a literature review and report of a case with a zoster-like cutaneous recurrence.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Combined Modality Therapy; Cyclophos | 2002 |
Acute erythroleukemia with t(3;5) accompanied by hepatocellular carcinoma.
Topics: Aclarubicin; Adolescent; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Carcinoma, Hepatoce | 1991 |
23 trials available for prednisolone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
Topics: Child; Child, Preschool; Cost-Benefit Analysis; Humans; Neoplasm Recurrence, Local; Nephrotic Syndro | 2022 |
MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Cyclophosphamide | 2022 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C | 2017 |
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Fe | 2018 |
A multicentre phase-II feasibility study evaluating gemcitabine/vinorelbine / prednisolone combination chemotherapy in relapsed / refractory Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chil | 2013 |
Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 2014 |
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Androstenes; Androstenol | 2014 |
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placeb
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carb | 2015 |
The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Central Nervous Sy | 2012 |
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide | 2007 |
Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasm | 1984 |
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Aged; Clinical Trials as Topic; Cobalt Radioisotopes; Cyclophosphamide; D | 1980 |
The management of stage IIIA Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1980 |
[Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration S | 1995 |
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burki | 1993 |
[Intra-arterial infusion chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Fema | 1996 |
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous | 1999 |
Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease | 2001 |
[Chemotherapy of advanced prostate cancer].
Topics: Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Diethylstilbestrol; Drug Eval | 1977 |
Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Calcium; Female; Fluid Therapy; Furosemide; Hum | 1992 |
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; | 1991 |
A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1991 |
A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc | 1989 |
94 other studies available for prednisolone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[A case of pembrolizumab-induced sclerosing cholangitis that was responsive to high-dose steroid therapy].
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Cholangitis, Sclerosing; Female; Humans; Neopl | 2021 |
A case of autoimmune hepatitis with thymoma and myasthenia gravis.
Topics: Adult; Female; Hepatitis, Autoimmune; Humans; Myasthenia Gravis; Neoplasm Recurrence, Local; Prednis | 2022 |
Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Disseminated Intravascular Coagul | 2022 |
The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.
Topics: Adult; Aged; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Femal | 2022 |
Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study.
Topics: Adult; Colitis, Ulcerative; Cost-Benefit Analysis; COVID-19; Humans; Infliximab; Neoplasm Recurrence | 2022 |
Immune-related colitis and pancreatitis treated with infliximab.
Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan | 2023 |
Immune-related colitis and pancreatitis treated with infliximab.
Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan | 2023 |
Immune-related colitis and pancreatitis treated with infliximab.
Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan | 2023 |
Immune-related colitis and pancreatitis treated with infliximab.
Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan | 2023 |
Immune-related colitis and pancreatitis treated with infliximab.
Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan | 2023 |
Immune-related colitis and pancreatitis treated with infliximab.
Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan | 2023 |
Immune-related colitis and pancreatitis treated with infliximab.
Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan | 2023 |
Immune-related colitis and pancreatitis treated with infliximab.
Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan | 2023 |
Immune-related colitis and pancreatitis treated with infliximab.
Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan | 2023 |
Granulocyte colony-stimulating factor-induced aortitis with temporal arteritis and monoarthritis.
Topics: Aortitis; Arthritis; Filgrastim; Giant Cell Arteritis; Granulocyte Colony-Stimulating Factor; Humans | 2023 |
Systemic steroid application for treatment of edematous anastomotic stenosis following delta-shaped anastomosis in laparoscopic distal gastrectomy: a case report.
Topics: Administration, Intravenous; Aged; Anastomosis, Surgical; Constriction, Pathologic; Dilatation; Edem | 2020 |
Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dendritic Cells | 2017 |
Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2017 |
Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; B7-H1 Antigen; Biomarkers, Tumor; Bone Neoplasm | 2017 |
Combination toceranib and lomustine shows frequent high grade toxicities when used for treatment of non-resectable or recurrent mast cell tumours in dogs: A European multicentre study.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dog Dise | 2017 |
Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Disease-Free Survival; | 2018 |
A Rare Case of Primary Histiocytic Sarcoma of the Stomach.
Topics: Abdomen; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophospham | 2018 |
Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis.
Topics: Aged; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Glucocortico | 2019 |
Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Cyclophospham | 2013 |
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cau | 2013 |
Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia.
Topics: Antineoplastic Agents; Child, Preschool; Disease-Free Survival; Female; Gene Rearrangement; Hematopo | 2015 |
Real-world experience with abiraterone.
Topics: Androstenes; Androstenols; Humans; Male; Neoplasm Recurrence, Local; Prednisolone; Prostate-Specific | 2014 |
Inoperable inflammatory myofibroblastic tumour of the para-nasal sinuses and orbit with recurrence responding to methotrexate and prednisolone: a case report.
Topics: Adult; Antimetabolites, Antineoplastic; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Me | 2015 |
Promising management of pazopanib-induced liver toxicity.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Female; H | 2015 |
Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2015 |
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Base Sequence; Carrier Proteins; Caspase 1; Child; Chil | 2015 |
Lung cancer associated with seronegative myasthenia gravis.
Topics: Blepharoptosis; Diplopia; Fatal Outcome; Humans; Lung Neoplasms; Male; Middle Aged; Myasthenia Gravi | 2015 |
Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.
Topics: Child, Preschool; Humans; Male; Neoplasm Recurrence, Local; Neuroblastoma; Opsoclonus-Myoclonus Synd | 2016 |
Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Fre | 2015 |
What Is Your Neurologic Diagnosis? Nasopharyngeal lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cat Diseases; Cats; Chemoradi | 2016 |
Polymyositis following autologous haematopoietic stem cell transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2016 |
Immune pancytopenia after chemotherapy in a patient with diffuse large B-cell lymphoma.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemothe | 2016 |
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother | 2017 |
Misdiagnosis due to the hook effect in prolactin assay.
Topics: Antineoplastic Agents; Cabergoline; Diabetes Insipidus, Neurogenic; Diagnostic Errors; Ergolines; Fe | 2008 |
[Minimal change nephrotic syndrome complicated with recurrence of malignant thymoma: an interesting case with remission due to steroid therapy of both nephrotic syndrome and thymoma].
Topics: Aged; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Neoplasm Recu | 2009 |
Refractory recurrent thymoma successfully treated with long-acting somatostatin analogue and prednisolone.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclopho | 2009 |
Vaginal obliteration in a woman with a history of cutaneous T-cell lymphoma: the results of combined chemotherapy-induced gonadal toxicity and lymphoma relapse.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 2010 |
[Primary neurolymphomatosis of the cervical nerve root].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2010 |
[Repetition of Helicobacter cinaedi infections during chemotherapy for malignant lymphoma].
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefozopran; Cephalospor | 2010 |
Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol.
Topics: Administration, Oral; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Administratio | 2011 |
Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; CD56 Antigen; Ch | 2011 |
Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 2011 |
Simultaneous occurrence of dermatomyositis and systemic sarcoidosis with recurrent breast cancer.
Topics: Aged; Breast Neoplasms; Dermatomyositis; Female; Humans; Neoplasm Recurrence, Local; Prednisolone; S | 2012 |
An immunoglobulin G4-related disease mimicking postoperative lung cancer recurrence.
Topics: Aged; Autoimmune Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Humans; | 2012 |
Cabazitaxel rechallenge at prostate-specific antigen relapse after previous cabazitaxel and docetaxel chemotherapy: case report.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Drug R | 2012 |
Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Mitox | 2003 |
Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ch | 2003 |
A new approach to the medical management of primary hypophysectomy in the treatment of recurrent carcinoma of the breast.
Topics: Breast; Breast Neoplasms; Carcinoma; Humans; Hypophysectomy; Mastectomy; Neoplasm Recurrence, Local; | 1958 |
[A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptoth | 2003 |
[Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cytarabine; Fatal | 2005 |
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
Topics: Age Factors; Antineoplastic Agents; Asparaginase; Cell Survival; Child; Cluster Analysis; Core Bindi | 2005 |
Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma.
Topics: Biomarkers, Tumor; Hemangioendothelioma; Hepatectomy; Hip Contracture; Humans; Infant; Liver Neoplas | 2005 |
Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspa | 2006 |
[Management of malignant gliomas diagnosed during pregnancy].
Topics: Abortion, Therapeutic; Adrenal Cortex Hormones; Adult; Algorithms; Anesthesia, General; Antineoplast | 2006 |
Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement.
Topics: Aged; Antigens, CD; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; CD8 Antigens; Cy | 2006 |
Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case report.
Topics: Blood Pressure; Calcineurin Inhibitors; Creatinine; Cyclosporine; Drug Therapy, Combination; Everoli | 2006 |
[NK/T-Cell lymphoma of nasopharynx].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosp | 2006 |
Inflammatory pseudotumour of the paranasal sinuses--a case report.
Topics: Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Diplopia; Disease Progression; Female; Gr | 2007 |
Long-term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; D | 2007 |
Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Dose- | 2008 |
[Successful corticosteroid therapy of a recurrent thymoma with pure red cell aplasia].
Topics: Aged; Humans; Male; Neoplasm Recurrence, Local; Pleural Neoplasms; Prednisolone; Red-Cell Aplasia, P | 2007 |
[Bone marrow transplantation in patients with leukemia].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graf | 1982 |
[Treatment procedure in generalized lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1982 |
[Drug therapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1981 |
[A case of primary malignant lymphoma of the brain which showed a remarkable response to prednisolone].
Topics: Antineoplastic Agents; Basal Ganglia; Brain Neoplasms; Humans; Lymphoma; Male; Middle Aged; Neoplasm | 1982 |
Results of oral steroid treatment in nasal polyposis.
Topics: Administration, Oral; Adult; Aged; Aspirin; Combined Modality Therapy; Drug Hypersensitivity; Female | 1994 |
Combination chemotherapy with a five-drug regimen for invasive thymoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormon | 1996 |
Steroid-responsive interstitial pneumonitis after fludarabine therapy.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Cough; Fatal Outcome; Glucocorticoids; Humans | 1997 |
Functional adrenocortical adenoma in a case with B cell chronic lymphoproliferative disorder.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined C | 1997 |
Granuloma annulare in a patient with malignant lymphoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormona | 1997 |
[Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 1997 |
Proportion of blasts with a clear halo around nucleoli at the end of induction therapy of acute myeloid leukemia correlates with achievement of complete remission, remission duration and relapse.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot | 1998 |
Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe?
Topics: Adult; Australia; Azathioprine; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cy | 1998 |
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubici | 1999 |
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiatio | 2001 |
Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Disease-Free Survival; Drug Sc | 2001 |
Long-term second remissions in acute lymphatic leukemia.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combinat | 1975 |
On long-term survivals in non-Hodgkin's lymphoma with 'gentle' treatment.
Topics: Adult; Aged; Child; Chlorambucil; Female; Follow-Up Studies; Humans; Lymph Nodes; Lymphoma; Male; Mi | 1976 |
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microgl | 1992 |
Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Co | 1992 |
Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Doxorubic | 1990 |
Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chil | 1990 |
Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined M | 1990 |
[Patterns of relapse in non-Hodgkin's lymphoma after complete remission induced by combination chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1985 |
Failure of conventional chemotherapy in aggressive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1987 |
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone.
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; | 1989 |
Endobronchial pseudolymphoma associated with Sjögren's syndrome. Report of a case.
Topics: Bronchial Neoplasms; Female; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Prednisolone | 1989 |
[Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug | 1989 |
Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression.
Topics: Azathioprine; Carcinoma, Hepatocellular; Cyclosporins; Humans; Liver Neoplasms; Liver Transplantatio | 1988 |
[Effect of combination chemotherapy with cis-dichlorodiammineplatinum on relapsed or therapy-resistant non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubici | 1988 |
[Course of lymphogranulomatosis with primary location below the diaphragm].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diaphragm; Female; Hodgkin | 1988 |
[Therapy against relapse in generalized lymphoblastic and immunoblastic lymphosarcomas in complete remission].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Eval | 1986 |
[Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
Topics: Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclo | 1985 |
[A case of pulmonary pseudolymphoma, presenting various symptoms, and responding remarkably to corticosteroid therapy].
Topics: Adult; Humans; Lung Neoplasms; Lymphoma; Male; Neoplasm Recurrence, Local; Prednisolone | 1985 |
Attempted induction of sarcoma in a Cape Chacma baboon with the Snyder-Theilen feline sarcoma virus.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cats; Fibrosarcoma; Haplorhini; Immunity; Male; Neoplas | 1973 |
[Prognosis in leukemia of childhood].
Topics: Adolescent; Antineoplastic Agents; BCG Vaccine; Child; Child, Preschool; Follow-Up Studies; Humans; | 1972 |
[Hormonal prevention of recurrence and metastasis in the complex treatment of breast cancer].
Topics: Adult; Aged; Androgens; Breast Neoplasms; Castration; Estrogens; Female; Humans; Mastectomy; Middle | 1968 |